Botulinum Toxin in Restless Legs Syndrome-A Randomized Double-Blind Placebo-Controlled Crossover Study.
Shivam Om MittalDuarte MachadoDiana RichardsonDivyanshu DubeyBahman JabbariPublished in: Toxins (2018)
IncoA injection lead to a reduction in severity of RLS symptoms, pain score, and quality of life, without any adverse effects.
Keyphrases
- botulinum toxin
- placebo controlled
- double blind
- chronic pain
- phase iii
- clinical trial
- phase ii
- pain management
- study protocol
- neuropathic pain
- phase ii study
- case report
- ultrasound guided
- sleep quality
- randomized controlled trial
- spinal cord injury
- depressive symptoms
- spinal cord
- physical activity
- squamous cell carcinoma
- rectal cancer